Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium-transporting ATPase subunit alpha gastric (ATP4A) is the catalytic component of the gastric proton pump, a P-type ATPase located in the secretory membranes of parietal cells in the stomach lining (UniProt P20648). It mediates the electroneutral exchange of intracellular H+ for extracellular K+ fueled by ATP hydrolysis, creating the highly acidic environment necessary for digestion and pathogen defense (StatPearls, Physiology, Acid Secretion). ATP4A is the primary pharmacological target for acid-related gastrointestinal disorders, including gastroesophageal reflux disease (GERD) and peptic ulcers. Therapeutic agents include irreversible proton pump inhibitors (PPIs) like omeprazole, which form covalent disulfide bonds with cysteine residues on the pump, and potassium-competitive acid blockers (PCABs) like vonoprazan, which provide rapid, reversible inhibition (PubChem, CID 4594). Chronic inhibition of ATP4A can lead to compensatory hypergastrinemia and alterations in the gut microbiome, presenting long-term safety considerations for patients. The enzyme consists of this alpha subunit and a beta subunit (ATP4B), where the alpha subunit contains the ATP binding site and the ion translocation pathway. Mutations in the ATP4A gene are associated with autoimmune gastritis and gastric neuroendocrine tumors due to achlorhydria-induced gastrin elevation. Understanding the structural dynamics of ATP4A has been pivotal in developing next-generation acid blockers that offer faster onset and more consistent acid control than traditional PPIs.
Covalent irreversible inhibition of the H+/K+-ATPase enzyme system by proton pump inhibitors (PPIs) and reversible competitive inhibition of the potassium-binding site by potassium-competitive acid blockers (PCABs).
7 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium-transporting ATPase subunit alpha gastric (ATP4A) (ATP4A).